Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Bipolar Disorders Treatment Market Size is estimated to reach USD 5.8 billion by 2032 and is expected to grow at 3.4% CARG during the forecast period. The market of the Bipolar Disorders Treatment is based on a number of market factors which altogether affect its environment. Another significant factor is the growing awakening and the comprehension of bipolar disorders. As public awareness about mental health grows, so does the understanding and treatment of bipolar disorders. This heightened consciousness will not only encourage those affected to seek treatment, but will also result in an enlargement of markets as more people are diagnosed and provided with required drugs.
The pharmaceutical industry makes a significant contribution to the market of Bipolar Disorders Treatment because it launches new medications for therapies regularly. The market offers a broad range of mood stabilizers, antipsychotics and antidepressants aimed at dealing with the varying signs of bipolar disorders. The ongoing researches and developments activities aim to raise the efficacy and tolerability level of the existing therapies and enable the healthcare providers with a wider range of therapeutic options. The entry of new drugs and of new lines of treatment poses severe competitive pressures to the pharmaceutical market.
The regulatory factors are the key drivers of the Bipolar Disorders Treatment market development. Stringent regulations and approval process (s) guarantee the safety and effectiveness of medications used to treat bipolar conditions. Changes in standards as well as approving or cancelling new medicine explicitly affect the way the market operates. Strict adherence to governmental regulations is a necessity for pharmaceutical companies who plan to introduce their innovative and effective therapies into the market.
Economic factors as well contribute to these dynamics of Bipolar Disorders Treatment. Affordability and accessibility of medicines determine the adoption of treatment plans in different segments of the society. Economic fluctuations, healthcare expenditure patterns, and mental health insurance, all influence the growth of the market and patient to acquire the prescribed medicine. The economic groundwork including healthcare policies and whether or not the treatment is reimbursed greatly determines the market and the level of access persons have to bipolar disorder treatments.
Patient education and awareness programs should be prioritized since they influence the Bipolar Disorders Treatment market. Educating people about the symptoms, outcomes and the available treatments for bipolar disorders contributes to early diagnosis and intervention. Increased awareness reduces the stigma about mental health, therefore more people are pushed to seek help from professionals.
Bipolar Disorders Treatment Market Highlights:
Bipolar Disorders Treatment Market Scenario
The bipolar disorders treatment market is anticipated to reach USD 5.8 Billion by 2032 at 3.4% CAGR during the forecast period 2023-2032. Bipolar disorder is a manic-depressive disorder, which is a type of mental illness. It is characterized by mood swings and mood episodes appear during the illness. Manic and depressive episodes are common mood episodes observed in bipolar disorders. The government initiatives for treatment of bipolar disorders, advancement in combination drugs, and growing demand for antidepressant drugs are expected to drive the growth of the market. Moreover, growing research and development activities conducted by government and nonprofit organizations are contributing to the growth of the market. For instance, Harvard University started Harvard brain science initiative (HBI) for R&D on bipolar disorders. This program has provided USD 3 million in funds to the research and development related to bipolar disorders. The side effects associated with therapy, low diagnosis rate, and dearth of experts may hamper the growth of the global market during the assessment period. Â
Bipolar Disorders Treatment Market Segmentation
The global bipolar disorders and treatment market has been segmented on the basis of drug class, mechanism of action, and end user. Based on drug type, the global market has been classified into mood stabilizer, antipsychotic drugs, antianxiety drugs, antidepressant drugs, anticonvulsants, and others. Based on the mechanism of action, the global market has been segmented into selective serotonin reuptake inhibitor, serotonin norepinephrine reuptake inhibitor, monoamine oxidase inhibitors, beta-blockers, tricyclic antidepressant drug, and others. The global market, by end user, has been segmented into hospitals and clinics, multispecialty centers, and others. The bipolar disorders treatment market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European market has been bifurcated into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bipolar disorders treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.  Key PlayersAllergan (Ireland), AstraZeneca (UK), Eli Lilly and Company(US), GlaxoSmithKline(UK), Abbott (US), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer Inc. (US), Cephalon Inc. (US), Otsuka America Pharmaceutical Inc. (US), and Gedeon Richter plc (Hungary) are some of the key players operating in the bipolar disorders treatment market.  Â
Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are likely to dominate the global bipolar disorders and treatment market owing to technological advancement, presence of major players in the region, well-established healthcare system, and increasing cases of bipolar disorders in the region. According to the National Institute of Mental Health (NIMH), approximately 3% of adults in the US were suffering from bipolar disorders in 2016 and this percentage is expected to increase significantly in the future due to changing lifestyles. Â The European market is expected to be the second-largest bipolar disorders and treatment market. The market growth in this region can be attributed to the increasing number of mental disorders, increasing government funding for treatment of bipolar disorders, and growing research and development activities related to mental health. For instance, in November 2017, Mental Health UK launched a partnership with Lloyds Banking Group to help bipolar disorder patients and to manage and improve their financial and mental health. Asia-Pacific is expected to be the fastest-growing bipolar disorders and treatment market during the forecast period owing to the increasing prevalence of genetic disorders, growing awareness about bipolar disorders, and rising investment by major players in the region. According to the Black Dog Institute, bipolar disorder is related with the genetic condition of an individual, if the parents are suffering from bipolar disorder it is more than 10% likely that their children will experience the same condition in future. The Middle East & Africa is expected to account for the smallest share of the bipolar disorders treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Bipolar disorders treatment market Segmentation
Bipolar disorders treatment Drug Type Outlook
- Mood Stabilizer
- Antipsychotic Drugs
- Antianxiety Drugs
- Antidepressant drugs
- Anticonvulsants
- Others
Bipolar disorders treatment Mechanism of Action Outlook
- Selective Serotonin Reuptake Inhibitor
- Serotonin Norepinephrine Reuptake Inhibitor
- Monoamine Oxidase Inhibitors
- Beta-Blockers
- Tricyclic Antidepressant Drug
- Others
Bipolar disorders treatment End User Outlook
- Hospitals and Clinics
- Multispecialty Centres
- Others
Bipolar disorders treatment Region Outlook
- Americas
- North America
- US
- Canada
- Latin America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Bipolar disorders treatment Key Players Outlook
- Allergan
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline
- Abbott
- Bristol-Myers Squibb
- Johnson & Johnson
- Pfizer Inc.
- Cephalon Inc.
- Otsuka America Pharmaceutical Inc.
- Gedeon Richter plc
- Others
Intended Audience
- Bipolar disorders and treatment centers
- Contract research organizations (CROs)
- Research and development (R&D) companies
- Government research laboratories
- Independent research laboratories
- Government and independent regulatory authorities
- Market research and consulting service providers
- Medical research laboratories
- Academic medical institutes and universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
